Compile Data Set for Download or QSAR
maximum 50k data
Found 28 Enz. Inhib. hit(s) with all data for entry = 10062
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511498(US11059792, Compound T12)
Affinity DataIC50:  11.3nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511511(US11059792, Compound T25)
Affinity DataIC50:  15.4nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511492(US11059792, Compound T6)
Affinity DataIC50:  19.4nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511495(US11059792, Compound T9)
Affinity DataIC50:  22.7nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511512(US11059792, Compound T26)
Affinity DataIC50:  27.7nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511494(US11059792, Compound T8)
Affinity DataIC50:  28.8nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511509(US11059792, Compound T23)
Affinity DataIC50:  31.1nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511489(US11059792, Compound T3)
Affinity DataIC50:  40.8nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511508(US11059792, Compound T22)
Affinity DataIC50:  47.8nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511510(US11059792, Compound T24)
Affinity DataIC50:  48.8nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511513(US11059792, Compound T27)
Affinity DataIC50:  53.1nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511496(US11059792, Compound T10)
Affinity DataIC50:  62.8nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511505(US11059792, Compound T19)
Affinity DataIC50:  82.7nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511493(US11059792, Compound T7)
Affinity DataIC50:  91.8nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511497(US11059792, Compound T11)
Affinity DataIC50:  93.2nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511503(US11059792, Compound T17)
Affinity DataIC50:  120nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511502(US11059792, Compound T16)
Affinity DataIC50:  132nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511491(US11059792, Compound TS)
Affinity DataIC50:  136nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511514(US11059792, Compound T28)
Affinity DataIC50:  138nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511487(US11059792, Compound T1)
Affinity DataIC50:  151nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511500(US11059792, Compound T14)
Affinity DataIC50:  222nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511499(US11059792, Compound T13)
Affinity DataIC50:  233nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511507(US11059792, Compound T21)
Affinity DataIC50:  407nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511488(US11059792, Compound T2)
Affinity DataIC50:  471nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511490(US11059792, Compound T4)
Affinity DataIC50:  662nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511504(US11059792, Compound T18)
Affinity DataIC50:  693nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511506(US11059792, Compound T20)
Affinity DataIC50:  1.00E+3nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511501(US11059792, Compound T15)
Affinity DataIC50: >3.00E+3nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND® 96 well plates (Corning, N.Y.) in a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent